New Mountain Capital
Private equity
Active
New York, United States
31
96M
29
1.29
12
0.06
11
- Areas of investment
Summary
New Mountain Capital appeared to be the VC, which was created in 2000. The leading representative office of defined VC is situated in the New York. The fund was located in North America if to be more exact in United States.
The standard case for the fund is to invest in rounds with 1-2 partakers. Despite the New Mountain Capital, startups are often financed by Venrock, Summit Partners, Noro-Moseley Partners. The meaningful sponsors for the fund in investment in the same round are Venrock, ARCH Venture Partners, Vestar Capital Partners. In the next rounds fund is usually obtained by Vestar Capital Partners, Frazier Healthcare Partners.
Comparing to the other companies, this New Mountain Capital performs on 2 percentage points more the average number of lead investments. The fund is constantly included in less than 2 investment rounds annually. The real fund results show that this VC is 55 percentage points more often commits exit comparing to other companies. The higher amount of exits for fund were in 2015. The usual things for fund are deals in the range of more than 100 millions dollars. The high activity for fund was in 2017. Despite it in 2019 the fund had an activity.
Among the most popular portfolio startups of the fund, we may highlight Ikaria, IRI, Stroz Friedberg. Among the most successful fund investment fields, there are Biotechnology, Medical. The fund has specific favorite in a number of founders of portfolio startups. Besides, a startup requires to be at the age of 11-15 years to receive the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.
The current fund was established by Steven Klinsky. Besides them, we counted 39 critical employees of this fund in our database.
Investor highlights
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 31
- Lead investments
- 12
- Exits
- 11
- Rounds per year
- 1.29
- Follow on index
- 0.06
- Investments by industry
- Health Care (10)
- Information Technology (6)
- Consulting (6)
- Medical (5)
- Software (5) Show 60 more
- Investments by region
-
- United States (30)
- Peak activity year
- 2017
- Number of Unicorns
- 3
- Number of Decacorns
- 3
- Number of Minotaurs
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 23
- Avg. valuation at time of investment
- 586M
- Group Appearance index
- 0.19
- Avg. company exit year
- 20
- Avg. multiplicator
- 3.67
- Strategy success index
- 0.40
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Ikaria | 01 Mar 2007 | Biotechnology, Medical, Therapeutics | Early Stage Venture | 280M | United States, New Jersey, Hampton |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.